The Pharmacy Times® Retail Clinical Role section is a comprehensive resource for clinical news and expert insights on issues pertaining to retail, community, and independent pharmacists.
May 16th 2025
Aficamten, a cardiac myosin inhibitor, gains FDA approval, offering hope for improved cardiovascular health in patients with obstructive hypertrophic cardiomyopathy.
The Value of Pharmacists in Treating Alzheimer Disease
November 10th 2021A pharmacist can offer up to date knowledge on the clinical evidence behind new drugs, serving as a source of guidance for patients amongst the controversy with aducanumab and other new medications for Alzheimer disease.
Read More
Combination of Casirivimab, Imdevimab Provides Long-Term Protection Against COVID-19
November 10th 2021A single 1200 mg subcutaneous dose of casirivimab and imdevimab (Regen-COV, Regeneron Pharmaceuticals), a preventative COVID-19 treatment, reduced the risk of contracting COVID-19 by 81.6% during months 2-8, according to additional results from a phase 3 trial published in The New England Journal of Medicine.
Read More
Study: Language Learning Associated With Cognitive Benefits for Older Adults
November 9th 2021The investigators found that older adults who studied Spanish had similar improvements to critical cognitive skills as those engaged in brain training activities specifically targeting those skills.
Read More